Top endocrinology stories: Menopause causes additional sleep complications, time-restricted feeding promising

This week, the most-read story in endocrinology was a report on how menopause brings additional complications to sleep disturbances.

Meeting news from ObesityWeek was also popular, including a pilot study that showed that time-restricted feeding did not negatively affect sleep among adults with obesity.

Other top stories included research that found that kisspeptin is a viable treatment option in type 2 diabetes and metabolic dysfunction, incretin therapy does not increase the risk for pancreatitis or pancreatic cancer in patients with type 2 diabetes and metabolic syndrome increases CV risk in prediabetes.

Menopause brings additional complications to sleep disturbances

Women’s sleep in midlife can be influenced by general aging and menopause — often at the same time — but health care providers can learn to spot differences to more effectively treat patients. Sleep disturbances are common for aging men and women, but hormonal changes brought on by menopause are unique and can require different, or additional, forms of treatment. Read more.

Time-restricted feeding shows promising sleep results in pilot study

NASHVILLE, Tenn. — In a pilot study of adults with obesity, time-restricted feeding did not negatively affect sleep quality or duration, according to data presented at the ObesityWeek annual meeting. Read more.

No increase for pancreatitis, pancreatic cancer with incretin therapy in type 2 diabetes

Second-line incretin therapies, including dipeptidyl-peptidase IV inhibitors and glucagon-like peptide-1 receptor agonists, do not increase the risk for pancreatitis or pancreatic cancer when added to metformin in type 2 diabetes, according to findings published in Diabetic Medicine. Read more.

Kisspeptin viable for treatment of type 2 diabetes, metabolic dysfunction

The hormone kisspeptin could be used in treating conditions beyond reproductive disorders, including addressing metabolic dysfunction, particularly in men with high glucose and low testosterone levels, according to data presented at the Society for Endocrinology BES annual meeting. Read more.

Metabolic syndrome increases CV risk in prediabetes

Metabolic syndrome increases the risk for major cardiovascular events in Chinese adults with prediabetes, according to findings published in the Journal of Diabetes Investigation. Read more.